Top

Published in:

01-06-2007 | Topic Paper

Laser treatment of benign prostatic hyperplasia

Author: Rainer M. Kuntz

Published in: World Journal of Urology | Issue 3/2007

Abstract

To evaluate the role of lasers that allow acute removal of obstructing tissue in the surgical treatment of benign prostatic hyperplasia (BPH). A MEDLINE search over the last 6 years focused on randomized trials, large case series and review articles. A total of more than 4,000 patients were analyzed with respect to the morbidity and outcome, and the advantages and disadvantages of the various lasers. Laser treatment of BPH has evolved from coagulation to enucleation. Blood loss is significantly reduced as compared to transurethral resection and open prostatectomy. Ablative/vaporizing techniques have recently become popular again with the marketing of new high-powered 80 W potassium-titanyl-phosphate (KTP) and 100 W holmium lasers. Vaporization immediately removes obstructing tissue, but tissue specimen cannot be obtained. KTP short-term results are promising, but long-term results and randomized trials are lacking. Postoperative volume reduction is less than with holmium laser enucleation of the prostate (HoLEP), and the KTP laser can be used for BPH treatment only. HoLEP allows whole lobes of the prostate to be removed. Prostates of all sizes can be operated on. It is at least as safe and effective as TURP and open prostatectomy, with significantly lower morbidity, as shown by several well-designed randomized clinical trials. It provides specimen for histological evaluation. In addition, the holmium laser can be used for the endourological treatment of stones, strictures and tumors. HoLEP appears to be a size-independent new “gold standard” in the surgical treatment of BPH.

Muschter R (2003) Free-beam and contact laser coagulation. J Endourol 17:579–585PubMedCrossRef

Laguna MP, Alivizatos G, de la Rosette JJMCH (2003) Interstitial laser coagulation treatment of benign prostatic hyperplasia: is it to be recommended? J Endourol 17:595–600PubMedCrossRef

Kuntz RM (2006) Current role of lasers in treatment of benign prostatic hyperplasia (BPH). Eur Urol 49:961–969PubMedCrossRef

Gilling PJ, Mackey M, Cresswell M, Kennett K, Kabalin JN, Fraundorfer MR (1999) Holmium laser versus transurethral resection of the prostate: a randomized prospective trial with 1-year follow up. J Urol 162:1640PubMedCrossRef

Westenberg A, Gilling P, Kennett K, Frampton C, Fraundorfer M (2004) Holmium laser resection of the prostate versus transurethral resection of the prostate: results of a randomized trial with 4-year minimum long-term follow up. J Urol 172:616–619PubMedCrossRef

Mottet N, Anidjar M, Bourdon O, Louis JF, Teillac P, Costa P, Le Duc A (1999) Randomized comparison of transurethral electroresection and holmium:YAG laser vaporization for symptomatic benign prostatic hyperplasia. J Endourol 13:127–130PubMedCrossRef

Tan AHH, Gilling PJ, Kennett KM, Frampton C, Westenberg AM, Fraundorfer MR (2003) A randomized trial comparing holmium laser enucleation of the prostate with transurethral resection of the prostate for the treatment of bladder outlet obstruction secondary to benign prostatic hyperplasia in large glands (40 to 200 grams). J Urol 170:1270–1274PubMedCrossRef

Montorsi F, Naspro R, Suardi N, Colombo R, Salonia A, Cestari A, Guazzoni G, Digirolamo V, Rigatti P (2006) Holmium laser enucleation of the prostate (HoLEP) versus open prostatectomy for prostates >70 g: 2-year follow-up. Eur Urol Suppl 5(2):234CrossRef

Kuntz RM, Ahyai S, Lehrich K, Fayad A (2004) Transurethral holmium laser enucleation of the prostate versus transurethral electrocautery resection of the prostate: a randomized prospective trial in 200 patients. J Urol 172:1012–1016PubMedCrossRef

10.

Kuntz RM, Lehrich K, Ahyai S (2004) Transurethral holmium laser enucleation of the prostate compared with transvesical open prostatectomy: 18-months-follow-up of a randomized study. J Endourol 18:189–191PubMedCrossRef

11.

Bouchier-Hayes DM, Anderson P, van Appledorn S, Bugeja P, Costello AJ (2006) A randomized trial comparing photoselective vaporization of the prostate (PVP) and transurethral resection of the prostate (TURP) in treatment of LUTS. J Urol Suppl 175:463

12.

Gordon S, Watson G (2006) Thulium laser enucleation of the prostate. Eur Urol Suppl 5(2):310CrossRef

13.

Moody J, Lingeman JE (2001) Holmium laser enucleation for prostate adenoma greater than 100 gm: comparison to open prostatectomy. J Urol 165:459–463PubMedCrossRef

14.

Bachmann A, Ruszat R, Straumann U, Wyler S, Schürch L, Forster T, Reich O, Lehmann K, Sulser T (2006) Photoselective vaporisation of the prostate (PVP) versus transurethral resection of the prostate (TURP). Eur Urol Suppl 5(2):236CrossRef

15.

Park J, Song SH, Lee SB, Hong B, Ahu TY (2006) Photoselective vaporization of the prostate for benign prostatic hypertrophy: comparison of short-term treatment outcomes with TURP. Eur Urol Suppl 5(2):235CrossRef

16.

Wilson LC, Gilling PJ (2005) From coagulation to enucleation: the use of lasers in surgery for benign prostatic hyperplasia. Nature Clin Pract Urol 2:443–448CrossRef

17.

Mc Allister WJ, Gilling PJ (2004) Vaporization of the prostate. Curr Opin Urol 14:31–34CrossRef

18.

Tooher R, Sutherland P, Costello A, Gilling P, Rees G, Maddern G (2004) A systematic review of holmium laser prostatectomy for benign prostatic hyperplasia. J Urol 171:1779–1791CrossRef

19.

Te AE (2004) The development of laser prostatectomy. BJU Int 93:262–265PubMedCrossRef

20.

Reich O, Bachmann A, Schneede P, Zaak D, Sulser T, Hofstetter A (2004) Experimental comparison of high power (80 W) potassium titanyl phosphate laser vaporization and transurethral resection of the prostate. J Urol 171:2502–2504PubMedCrossRef

21.

Ruszat R, Bachman A, Wyler S, Seifert HH, Forster T, Reich O, Sulser T (2006) Photoselective vaporisation of the prostate (PVP): functional outcome and adverse events after 285 procedures. Eur Urol Suppl 5(2):233CrossRef

22.

Reddy B, Gouzales RR, Sandhu JS, Kaplan SA, Te AE (2005) KTP photoselective vaporization of the prostate: New York Presbyterian–Cornell experience. SIU meeting on prostate disease, Bariloche Argentinia, 29.9-1.10.2005

23.

Malloy T, Sandhu J, Smith A, Reddy B, Harryhill J, Kaplan S, Te A (2005) Photoselective vaporization of the prostate (PVP) in anticoagulated patients: a multicenter retrospective evaluation of feasibility. J Urol Suppl 173:423

24.

Sandhu JS, Ng C, Vanderbrink BA, Egan C, Kaplan SA, Te AE (2004) High-power potassium-titanyl-phosphate photoselective laser vaporization of prostate for treatment of benign prostatic hyperplasia in men with large prostates. Urology 64:1155–1159PubMedCrossRef

25.

Te AE, Malloy TR, Stein BS, Ulchaker JC, Nseyo UO, Hai MA, Malek RS (2004) Photoselective vaporization of the prostate for the treatment of benign prostatic hyperplasia: 12-month results from the first United States multicenter prospective trial. J Urol 172:1404–1408PubMedCrossRef

26.

Ruszat R, Sulser T, Wyler S, Forster T, Bachmann A, Leippold T (2006) Transurethrale Prostatektomie bei über 80 Jährigen—Ist die photoselektive Vaporisation der Prostata eine sichere Alternative? Urologie 45(Suppl 1):113

27.

Yakupogly YK, Donmezer S, Mestci B, Saglam R, Simsek ÜS (2006) Successful treatment of BPH over 100 ml with KTP laser. J Urol Suppl 175:491

28.

Te AE (2006) The next generation in laser treatments and the role of the greenlight high-performance system laser. Rev Urol Suppl 8:24–30

29.

Gilling PJ, Fraundorfer MR (1998) Holmium laser prostatectomy: a technique in evolution. Curr Opin Urol 8:11–15PubMedCrossRef

30.

Tan AAH, Gilling PJ, Kennett KM, Fletcher H, Fraundorfer MR (2003) Long-term results of high-power holmium laser vaporization (ablation) of the prostate. BJU Int 92:707–709PubMedCrossRef

31.

Pedraza R, Samadi A, Eshghi M (2004) Holmium laser enucleation of the prostate in critically ill patients with technique modification. J Endourol 18:795–798PubMedCrossRef

32.

Elzayat EA, Elhilali MM (2006) Experience of 603 cases treated with holmium laser enucleation of the prostate (HoLEP) for symptomatic benign prostatic hyperplasia. J Urol Suppl 175:490

33.

Elzayat EA, Elhilali MM (2006) Holmium laser enucleation of the prostate (HoLEP): the endourological alternative to open prostatectomy. Eur Urol 49:87–91PubMedCrossRef

34.

Kuntz RM, Lehrich K, Ahyai S (2004) Does perioperative outcome of transurethral holmium laser enucleation of the prostate depend on prostate size? J Endourol 18:183–188PubMedCrossRef

35.

Miller NL, Matlaga BR, Kim SC, Kuo RL, Watkins SL, Lingeman JE (2006) Holmium laser enucleation of the prostate: effect on prostate volume. J Urol Suppl 175:490

36.

Naspro R, Freschi M, Salonia A, Guazzoni G, di Givolamo V, Scattoni RCV, Rigatti P, Montorsi F (2004) Holmium laser enucleation versus transurethral resection of the prostate. Are histological findings comparable? J Urol 171:1203–1206PubMedCrossRef

37.

Larner TRG, Agarwal D, Costello AJ (2003) Day-case holmium laser enucleation of the prostate for gland volumes of <60 ml: early experience. BJU Int 91:61–64PubMedCrossRef

38.

Kuo R, Paterson R, Siqueira T, Watkins S, Simmons G, Steele R, Lingeman J (2003) Holmium laser enucleation of the prostate: morbidity in a series of 206 patients. Urology 62:59–63PubMedCrossRef

39.

El-Hakim A, Elhilali MM (2002) Holmium laser enucleation can be taught: the first learning experience. BJU Int 90:863–869PubMedCrossRef

40.

Seki N, Mochida O, Kinukawa N, Sagiyama K, Naito S (2003) Holmium laser enucleation for prostatic adenoma: analysis of learning curve over the course of 70 consecutive cases. J Urol 170:1847–1850PubMedCrossRef

41.

Kundu S, Roehl KA, Loeb ST, Gashti SN, Smith N, McVary KT, Catalona WJ (2006) Could laser vaporization of the prostate for BPH compromise prostate cancer detection? J Urol Suppl 175:462

Title: Laser treatment of benign prostatic hyperplasia
Author: Rainer M. Kuntz
Publication date: 01-06-2007
Publisher: Springer-Verlag
Published in: World Journal of Urology / Issue 3/2007
Print ISSN: 0724-4983
Electronic ISSN: 1433-8726
DOI: https://doi.org/10.1007/s00345-007-0170-y

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Laser treatment of benign prostatic hyperplasia

Abstract

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 3/2007

Diagnostic efficacy of transrectal ultrasound-guided biopsy of the prostatic fossa in patients with rising PSA following radical prostatectomy

RevoLix™ vaporesection of the prostate: initial results of 54 patients with a 1-year follow-up

Technical aspects of lasers in urology

Epidemiology of urinary bladder cancer: from tumor development to patient’s death

Steroid- and calcineurin inhibitor free immunosuppression in kidney transplantation: state of the art and future developments

The future of lasers in urology